Category
Primary
pharmaceutical-drugs · embed-ft 0.7
Tree path
Medical Health › Pharmaceutical Drugs
Group (tier-1)
Tech stack
AI readiness
AI training policy
allowed
Terms of Service
found · https://www.ucb-usa.com/Legal
AI-bot protection
AI files
Compliance (GEO / GDPR)
TLD
Overview
Title
KYGEVVI® (doxecitine and doxribtimine) — Powder for Oral Solution
Description
The first and only FDA-approved treatment for pediatric and adult patients with thymidine kinase 2 deficiency (TK2d) with an age of symptom onset on or before 12 years.
Final URL
Language
en (html)
Scanned at
2026-06-23 23:38:34